Malignant Testicular Germ Cell Tumor
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Testicular Germ Cell Tumor trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Testicular Germ Cell Tumor trials you may qualify forThis phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is re…
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimens…
Adolescents and young adults (AYA) diagnosed with cancer experience unique challenges after completing treatment and face distinct barriers to optimal care and…
This study will evaluate the effectiveness of T-DXd in patients with HER2-positive (IHC 3+) locally advanced, unresectable, or metastatic solid tumors who have…
Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24…
This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it…
TRANSCEND-XR is a European research project designed to better support adolescents and young adults who have been cured of testicular cancer. Even after treatme…
This trial tests if AI can help make medical info clear and readable. Many patients struggle to find medical informations that easy to read and understand from…